{"count":220833,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=727","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=725","results":[{"created":"2022-10-06T13:51:21.192134+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.448","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NOTCH2 were changed from Hajdu-Cheney syndrome to Alagille syndrome 2 (MIM#610205); Hajdu-Cheney syndrome (MIM#102500)","entity_name":"NOTCH2","entity_type":"gene"},{"created":"2022-10-06T13:50:43.428770+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.447","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NOTCH2 as Red List (low evidence)","entity_name":"NOTCH2","entity_type":"gene"},{"created":"2022-10-06T13:50:43.419903+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.447","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: notch2 has been classified as Red List (Low Evidence).","entity_name":"NOTCH2","entity_type":"gene"},{"created":"2022-10-06T13:50:28.478127+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.446","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NOTCH2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Alagille syndrome 2 (MIM#610205), Hajdu-Cheney syndrome (MIM#102500); Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"NOTCH2","entity_type":"gene"},{"created":"2022-10-06T13:50:20.971100+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.446","user_name":"David Amor","item_type":"entity","text":"reviewed gene: ORC1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Meier-Gorlin syndrome 1; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ORC1","entity_type":"gene"},{"created":"2022-10-06T13:49:44.229464+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.446","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NOG as ready","entity_name":"NOG","entity_type":"gene"},{"created":"2022-10-06T13:49:44.220404+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.446","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nog has been classified as Red List (Low Evidence).","entity_name":"NOG","entity_type":"gene"},{"created":"2022-10-06T13:49:40.516193+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.446","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NOG were changed from Symphalangism, proximal, 1A to Brachydactyly, type B2 - MIM#611377; Multiple synostoses syndrome 1 (MIM#186500); Stapes ankylosis with broad thumbs and toes (MIM#184460); Symphalangism, proximal, 1A (MIM#185800); Tarsal-carpal coalition syndrome (MIM#186570)","entity_name":"NOG","entity_type":"gene"},{"created":"2022-10-06T13:49:28.766215+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.445","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NOG as Red List (low evidence)","entity_name":"NOG","entity_type":"gene"},{"created":"2022-10-06T13:49:28.758394+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.445","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nog has been classified as Red List (Low Evidence).","entity_name":"NOG","entity_type":"gene"},{"created":"2022-10-06T13:49:17.435391+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.444","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: NOG: Changed rating: RED","entity_name":"NOG","entity_type":"gene"},{"created":"2022-10-06T13:49:09.710817+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.444","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NOG: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Brachydactyly, type B2 - MIM#611377, Multiple synostoses syndrome 1 (MIM#186500), Stapes ankylosis with broad thumbs and toes (MIM#184460), Symphalangism, proximal, 1A (MIM#185800), Tarsal-carpal coalition syndrome (MIM#186570); Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"NOG","entity_type":"gene"},{"created":"2022-10-06T13:48:16.664016+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.444","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NNT as ready","entity_name":"NNT","entity_type":"gene"},{"created":"2022-10-06T13:48:16.654817+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.444","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nnt has been classified as Green List (High Evidence).","entity_name":"NNT","entity_type":"gene"},{"created":"2022-10-06T13:48:12.698810+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.444","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NNT were set to ","entity_name":"NNT","entity_type":"gene"},{"created":"2022-10-06T13:48:01.728356+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.443","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: NNT.","entity_name":"NNT","entity_type":"gene"},{"created":"2022-10-06T13:47:53.268008+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.443","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NNT: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency - MIM#614736; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NNT","entity_type":"gene"},{"created":"2022-10-06T13:47:15.403624+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.443","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NKX2-1 as ready","entity_name":"NKX2-1","entity_type":"gene"},{"created":"2022-10-06T13:47:15.395514+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.443","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nkx2-1 has been classified as Green List (High Evidence).","entity_name":"NKX2-1","entity_type":"gene"},{"created":"2022-10-06T13:47:12.223841+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.443","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NKX2-1 were changed from Choreoathetosis, hypothyroidism, and neonatal respiratory distress to Choreoathetosis, hypothyroidism, and neonatal respiratory distress MIM#610978","entity_name":"NKX2-1","entity_type":"gene"},{"created":"2022-10-06T13:47:07.363505+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.442","user_name":"David Amor","item_type":"entity","text":"reviewed gene: OPA1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Optic atrophy 1; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"OPA1","entity_type":"gene"},{"created":"2022-10-06T13:46:55.935077+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.442","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NKX2-1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Choreoathetosis, hypothyroidism, and neonatal respiratory distress MIM#610978; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"NKX2-1","entity_type":"gene"},{"created":"2022-10-06T13:46:04.540876+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.442","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NIPBL as ready","entity_name":"NIPBL","entity_type":"gene"},{"created":"2022-10-06T13:46:04.532015+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.442","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nipbl has been classified as Red List (Low Evidence).","entity_name":"NIPBL","entity_type":"gene"},{"created":"2022-10-06T13:46:00.718163+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.442","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NIPBL were changed from Cornelia de Lange syndrome to Cornelia de Lange syndrome 1, MIM# 122470","entity_name":"NIPBL","entity_type":"gene"},{"created":"2022-10-06T13:45:46.630996+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.441","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NIPBL as Red List (low evidence)","entity_name":"NIPBL","entity_type":"gene"},{"created":"2022-10-06T13:45:46.621759+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.441","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nipbl has been classified as Red List (Low Evidence).","entity_name":"NIPBL","entity_type":"gene"},{"created":"2022-10-06T13:45:29.910171+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.440","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NIPBL: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Cornelia de Lange syndrome 1, MIM# 122470; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"NIPBL","entity_type":"gene"},{"created":"2022-10-06T13:44:56.484344+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.440","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NIPAL4 as ready","entity_name":"NIPAL4","entity_type":"gene"},{"created":"2022-10-06T13:44:56.476487+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.440","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nipal4 has been classified as Green List (High Evidence).","entity_name":"NIPAL4","entity_type":"gene"},{"created":"2022-10-06T13:44:53.132816+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.440","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NIPAL4 were changed from Ichthyosis, autosomal recessive to Ichthyosis, congenital, autosomal recessive 6, MIM# 612281","entity_name":"NIPAL4","entity_type":"gene"},{"created":"2022-10-06T13:44:41.792394+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.439","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NIPAL4 were set to ","entity_name":"NIPAL4","entity_type":"gene"},{"created":"2022-10-06T13:44:25.534182+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.438","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NIPAL4: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Ichthyosis, congenital, autosomal recessive 6, MIM# 612281; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NIPAL4","entity_type":"gene"},{"created":"2022-10-06T13:44:21.483849+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.438","user_name":"David Amor","item_type":"entity","text":"reviewed gene: OFD1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Orofaciodigital syndrome I; Mode of inheritance: X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","entity_name":"OFD1","entity_type":"gene"},{"created":"2022-10-06T13:43:25.832775+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.438","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NHLRC1 as ready","entity_name":"NHLRC1","entity_type":"gene"},{"created":"2022-10-06T13:43:25.823380+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.438","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nhlrc1 has been classified as Red List (Low Evidence).","entity_name":"NHLRC1","entity_type":"gene"},{"created":"2022-10-06T13:43:22.447122+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.438","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NHLRC1 were changed from Myoclonic epilepsy of Lafora to Epilepsy, progressive myoclonic 2B (Lafora), MIM# 254780","entity_name":"NHLRC1","entity_type":"gene"},{"created":"2022-10-06T13:43:09.920886+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.437","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NHLRC1 as Red List (low evidence)","entity_name":"NHLRC1","entity_type":"gene"},{"created":"2022-10-06T13:43:09.909120+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.437","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nhlrc1 has been classified as Red List (Low Evidence).","entity_name":"NHLRC1","entity_type":"gene"},{"created":"2022-10-06T13:42:57.868307+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.436","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NHLRC1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Epilepsy, progressive myoclonic 2B (Lafora), MIM# 254780; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NHLRC1","entity_type":"gene"},{"created":"2022-10-06T13:42:04.484885+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.436","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NHEJ1 as ready","entity_name":"NHEJ1","entity_type":"gene"},{"created":"2022-10-06T13:42:04.469690+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.436","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nhej1 has been classified as Green List (High Evidence).","entity_name":"NHEJ1","entity_type":"gene"},{"created":"2022-10-06T13:41:57.678186+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.436","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: NHEJ1.","entity_name":"NHEJ1","entity_type":"gene"},{"created":"2022-10-06T13:41:48.697750+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.436","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NHEJ1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, MIM# 611291; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NHEJ1","entity_type":"gene"},{"created":"2022-10-06T13:41:09.532238+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.436","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NGLY1 as ready","entity_name":"NGLY1","entity_type":"gene"},{"created":"2022-10-06T13:41:09.523713+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.436","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ngly1 has been classified as Red List (Low Evidence).","entity_name":"NGLY1","entity_type":"gene"},{"created":"2022-10-06T13:41:06.096006+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.436","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NGLY1 were changed from Developmental delay, multifocal epilepsy & abnormal liver function to Congenital disorder of deglycosylation, MIM# 615273","entity_name":"NGLY1","entity_type":"gene"},{"created":"2022-10-06T13:40:55.794226+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.435","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NGLY1 as Red List (low evidence)","entity_name":"NGLY1","entity_type":"gene"},{"created":"2022-10-06T13:40:55.784935+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.435","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ngly1 has been classified as Red List (Low Evidence).","entity_name":"NGLY1","entity_type":"gene"},{"created":"2022-10-06T13:40:42.069575+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.434","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NGLY1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Congenital disorder of deglycosylation, MIM# 615273; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NGLY1","entity_type":"gene"},{"created":"2022-10-06T13:40:08.014190+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.434","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NF2 as ready","entity_name":"NF2","entity_type":"gene"},{"created":"2022-10-06T13:40:08.005894+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.434","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nf2 has been classified as Red List (Low Evidence).","entity_name":"NF2","entity_type":"gene"},{"created":"2022-10-06T13:40:04.454061+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.434","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NF2 were changed from Neurofibromatosis 2 to Neurofibromatosis, type 2 (MIM# 101000)","entity_name":"NF2","entity_type":"gene"},{"created":"2022-10-06T13:39:52.714450+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.433","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NF2 as Red List (low evidence)","entity_name":"NF2","entity_type":"gene"},{"created":"2022-10-06T13:39:52.687873+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.433","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nf2 has been classified as Red List (Low Evidence).","entity_name":"NF2","entity_type":"gene"},{"created":"2022-10-06T13:39:41.252397+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.432","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NF2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Neurofibromatosis, type 2 (MIM# 101000); Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"NF2","entity_type":"gene"},{"created":"2022-10-06T13:38:29.597372+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.432","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NF1 as ready","entity_name":"NF1","entity_type":"gene"},{"created":"2022-10-06T13:38:29.587600+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.432","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nf1 has been classified as Green List (High Evidence).","entity_name":"NF1","entity_type":"gene"},{"created":"2022-10-06T13:38:26.494257+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.432","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NF1 were changed from Neurofibromatosis, type 1 to Neurofibromatosis, type 1, MIM# 162200","entity_name":"NF1","entity_type":"gene"},{"created":"2022-10-06T13:38:16.212554+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.431","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NF1 were set to ","entity_name":"NF1","entity_type":"gene"},{"created":"2022-10-06T13:38:02.309780+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.430","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NF1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Neurofibromatosis, type 1, MIM# 162200; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"NF1","entity_type":"gene"},{"created":"2022-10-06T13:36:50.585854+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.430","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NEUROG3 as ready","entity_name":"NEUROG3","entity_type":"gene"},{"created":"2022-10-06T13:36:50.566819+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.430","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: neurog3 has been classified as Green List (High Evidence).","entity_name":"NEUROG3","entity_type":"gene"},{"created":"2022-10-06T13:36:43.504648+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.430","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: NEUROG3.","entity_name":"NEUROG3","entity_type":"gene"},{"created":"2022-10-06T13:36:31.981306+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.430","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NEUROG3: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Diarrhoea 4, malabsorptive, congenital, MIM# 610370; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NEUROG3","entity_type":"gene"},{"created":"2022-10-06T13:35:46.086479+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.430","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NEU1 as ready","entity_name":"NEU1","entity_type":"gene"},{"created":"2022-10-06T13:35:46.078245+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.430","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: neu1 has been classified as Red List (Low Evidence).","entity_name":"NEU1","entity_type":"gene"},{"created":"2022-10-06T13:35:42.040964+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.430","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NEU1 were changed from Sialidosis to Sialidosis, type I and type II, MIM# 256550","entity_name":"NEU1","entity_type":"gene"},{"created":"2022-10-06T13:35:30.483889+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.429","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NEU1 as Red List (low evidence)","entity_name":"NEU1","entity_type":"gene"},{"created":"2022-10-06T13:35:30.476353+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.429","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: neu1 has been classified as Red List (Low Evidence).","entity_name":"NEU1","entity_type":"gene"},{"created":"2022-10-06T13:35:17.945935+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.428","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NEU1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Sialidosis, type I and type II, MIM# 256550; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NEU1","entity_type":"gene"},{"created":"2022-10-06T13:34:26.490969+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.428","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NEK8 as ready","entity_name":"NEK8","entity_type":"gene"},{"created":"2022-10-06T13:34:26.481980+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.428","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nek8 has been classified as Red List (Low Evidence).","entity_name":"NEK8","entity_type":"gene"},{"created":"2022-10-06T13:34:14.374467+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.428","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NEK8 as Red List (low evidence)","entity_name":"NEK8","entity_type":"gene"},{"created":"2022-10-06T13:34:14.365932+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.428","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nek8 has been classified as Red List (Low Evidence).","entity_name":"NEK8","entity_type":"gene"},{"created":"2022-10-06T13:34:01.662215+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.427","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NEK8: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Renal-hepatic-pancreatic dysplasia 2, MIM# 615415; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NEK8","entity_type":"gene"},{"created":"2022-10-06T13:33:23.249132+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.427","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NEK1 as ready","entity_name":"NEK1","entity_type":"gene"},{"created":"2022-10-06T13:33:23.240560+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.427","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nek1 has been classified as Red List (Low Evidence).","entity_name":"NEK1","entity_type":"gene"},{"created":"2022-10-06T13:33:17.280304+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.427","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NEK1 as Red List (low evidence)","entity_name":"NEK1","entity_type":"gene"},{"created":"2022-10-06T13:33:17.271243+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.427","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nek1 has been classified as Red List (Low Evidence).","entity_name":"NEK1","entity_type":"gene"},{"created":"2022-10-06T13:33:03.770378+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.426","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NEK1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Short-rib thoracic dysplasia 6 with or without polydactyly, MIM# 263520; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NEK1","entity_type":"gene"},{"created":"2022-10-06T13:32:30.866927+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.426","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NEFL as ready","entity_name":"NEFL","entity_type":"gene"},{"created":"2022-10-06T13:32:30.855582+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.426","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nefl has been classified as Red List (Low Evidence).","entity_name":"NEFL","entity_type":"gene"},{"created":"2022-10-06T13:32:25.457449+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.426","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NEFL were changed from Charcot-Marie-Tooth disease to Charcot-Marie-Tooth disease, dominant intermediate G, MIM# 617882; Charcot-Marie-Tooth disease, type 1F, MIM# 607734; Charcot-Marie-Tooth disease, type 2E 607684","entity_name":"NEFL","entity_type":"gene"},{"created":"2022-10-06T13:32:16.772867+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.425","user_name":"David Amor","item_type":"entity","text":"reviewed gene: OCRL: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Lowe syndrome; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"OCRL","entity_type":"gene"},{"created":"2022-10-06T13:32:13.062414+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.425","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: NEFL was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"NEFL","entity_type":"gene"},{"created":"2022-10-06T13:32:03.647298+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.424","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NEFL as Red List (low evidence)","entity_name":"NEFL","entity_type":"gene"},{"created":"2022-10-06T13:32:03.583216+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.424","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nefl has been classified as Red List (Low Evidence).","entity_name":"NEFL","entity_type":"gene"},{"created":"2022-10-06T13:31:49.380694+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.423","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NEFL: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Charcot-Marie-Tooth disease, dominant intermediate G, MIM# 617882, Charcot-Marie-Tooth disease, type 1F, MIM# 607734, Charcot-Marie-Tooth disease, type 2E 607684; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"NEFL","entity_type":"gene"},{"created":"2022-10-06T13:31:04.539055+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.423","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NEB as ready","entity_name":"NEB","entity_type":"gene"},{"created":"2022-10-06T13:31:04.529280+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.423","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: neb has been classified as Red List (Low Evidence).","entity_name":"NEB","entity_type":"gene"},{"created":"2022-10-06T13:31:00.880906+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.423","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NEB were changed from Nemaline myopathy to Nemaline myopathy 2, autosomal recessive 256030; Arthrogryposis multiplex congenita 6, MIM# 619334","entity_name":"NEB","entity_type":"gene"},{"created":"2022-10-06T13:30:49.501720+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.422","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NEB as Red List (low evidence)","entity_name":"NEB","entity_type":"gene"},{"created":"2022-10-06T13:30:49.492918+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.422","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: neb has been classified as Red List (Low Evidence).","entity_name":"NEB","entity_type":"gene"},{"created":"2022-10-06T13:30:37.725306+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.421","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NEB: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Nemaline myopathy 2, autosomal recessive 256030, Arthrogryposis multiplex congenita 6, MIM# 619334; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NEB","entity_type":"gene"},{"created":"2022-10-06T13:29:51.676185+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.421","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NDP as ready","entity_name":"NDP","entity_type":"gene"},{"created":"2022-10-06T13:29:51.666574+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.421","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ndp has been classified as Red List (Low Evidence).","entity_name":"NDP","entity_type":"gene"},{"created":"2022-10-06T13:29:47.930278+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.421","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NDP were changed from Norrie disease to Norrie disease, MIM# 310600","entity_name":"NDP","entity_type":"gene"},{"created":"2022-10-06T13:29:35.057051+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.420","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NDP as Red List (low evidence)","entity_name":"NDP","entity_type":"gene"},{"created":"2022-10-06T13:29:35.041942+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.420","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ndp has been classified as Red List (Low Evidence).","entity_name":"NDP","entity_type":"gene"}]}